About: Sera Prognostics, Inc., a women's health company, discovers, develops, and commercializes blood-based biomarker tests, and predictive analytic products and services in the United States. The company develops the PreTRM test, a non-invasive blood test given to a pregnant woman, carrying a single fetus, during weeks 18 through 20 of gestation. It is also involved in the development of a pipeline of novel blood-based biomarker tests and predictive analytic products and services for pregnancy related conditions, such as time-to-birth, predictive analytics product, pregnancy risk prediction panel, preeclampsia, and fetal growth restriction. The company was incorporated in 2008 and is headquartered in Salt Lake City, Utah.
Sector: Healthcare
Industry: Medical Devices
Latest price: $2.06 (-0.48%)
SERA NASDAQ Sera Prognostics Inc
Sera Prognostics Inc share price
Atividade de preço de SERA
Último preço
$ 2,060
Variação (24h)
-0,01 USD (0,48%)
Volume
17.79K
Volume (média 4 sem.)
-
Abertura
$ 2,10
Variação do dia
$ 2,03 - $ 2,10
Fechamento anterior
$ 2,07
Último negócio
29 Oct, 8:22 pm GMT+0
Atrasado
29 Oct, 8:22 pm GMT+0
SERA price performance
Atrasado
29 Oct, 8:22 pm GMT+0
quote.marketSignals